Heterocyclic carboxylic acid ester derivative
US9346821B2 · kind B2 · utility
5Cited by
7References
21Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 6, 2013 |
| Grant date | May 24, 2016 |
| Priority date | — |
| Expiry date | Dec 6, 2033 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides a blood glucose elevation inhibitor having a serine protease inhibitory action, which is a novel therapeutic or prophylactic agent for obesity. A compound represented by the following formula (I)wherein each symbol is as described in the specification, or a pharmaceutically acceptable salt thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.